Phase III clinical trial for treatment of dry eye syndrome
A Phase III trial looks to treat dry eye syndrome using a sterile, preservative-free eye drop formulation that has thymosin beta 4 as its active ingredient...
List view / Grid view
A Phase III trial looks to treat dry eye syndrome using a sterile, preservative-free eye drop formulation that has thymosin beta 4 as its active ingredient...